# Summit Biosciences Inc. - Inspection Records

Source: https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976

> Inspection records and compliance data for Summit Biosciences Inc. in Lexington, Kentucky. Access full analysis and detailed observations.

---

## Details

- Name: Summit Biosciences Inc.
- FEI Number: 3007577023
- City: Lexington
- State: Kentucky
- Country Name: United States
- Address Line 1: 1513 Bull Lea Rd
- Zip Code: 40511
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - Summit Biosciences Inc. - 2025-02-21](https://www.keypedia.com/records/483/summit-biosciences-inc/f1c02c76-4a6d-4a2a-96f8-502730a91773) — source: FDA, date: February 21, 2025
- [FDA Inspection 1261583 - Summit Biosciences Inc. - 2025-02-21](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/fbf78c84-7d7e-4694-9f67-ee101159342d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2025
- [FDA Inspection 1218227 - Summit Biosciences Inc. - 2023-09-14](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/4dfd068f-13de-4321-897b-877c72d3592b) — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2023
- [FDA Inspection 1121348 - Summit Biosciences Inc. - 2020-02-04](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/19d10378-051a-47ff-b8a8-b4e78e1d0333) — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2020
- [FDA Inspection 1018004 - Summit Biosciences Inc. - 2017-06-23](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/c0f4cc8b-fd56-4d6f-8d17-f9e0da7f4f8a) — classification: No Action Indicated (NAI), source: FDA, date: June 23, 2017
- [FDA Inspection 933643 - Summit Biosciences Inc. - 2015-06-18](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/57f4ace6-9ae3-4f29-8fe5-f8e2e4db37e2) — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2015
- [FDA Inspection 868633 - Summit Biosciences Inc. - 2014-02-28](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/38015c8a-d915-445e-93fb-f6c08c9fe811) — classification: No Action Indicated (NAI), source: FDA, date: February 28, 2014

## Related Companies

- [BioDuro, LLC](https://www.keypedia.com/companies/bioduro-llc/ea6debd9-54f2-4570-a8b6-f62b6f60c207)
- [Mayne Pharma International PTY LTD](https://www.keypedia.com/companies/mayne-pharma-international-pty-ltd/073fd71d-43f6-4a53-9597-0951e7459d08)
- [AstraZeneca Nijmegen B.V.](https://www.keypedia.com/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/88a4c8ee-d792-4747-acb7-de304d1efbb6)
- [Nostrum Laboratories, Inc.](https://www.keypedia.com/companies/nostrum-laboratories-inc/c9042755-fe46-4113-b071-6c8168af53e2)
- [Colgate-Palmolive Company](https://www.keypedia.com/companies/colgate-palmolive-company/7db665f6-094f-4de5-bf3b-c2528e2a223b)
- [Mipharm S.p.A.](https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc)
- [Cosette Pharmaceuticals NC Laboratories, LLC](https://www.keypedia.com/companies/cosette-pharmaceuticals-nc-laboratories-llc/4f90e360-99ea-4457-a022-4950a8ea7644)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/adf0ad1b-ed79-4d72-a254-d42d5a982384)
- [PF Soins de Sante SRI](https://www.keypedia.com/companies/pf-soins-de-sante-sri/9e60bbed-a0ce-4353-ae08-a599608d5bd4)

## Related Officers

- [Ucheabuchi C. Chudi-nwankwor](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)